Unintentional opacification of the duct of Wirsung occurred in 32% of the patients, among whom 36 39.6% developed hyperamylasemia while six of these patients 66.7% were among the nine who developed pancreatitis and 7 13.5% were in the normal group. Th is group contained the largest number of patients who developed pancreatitis following ERCP with a statistically signifi cant relation of p=0.000. It was 4.65 times more probable for these patients to develop pancreatitis following ERCP: OR= 4.65, 95% CI 1.11 to 19.46.
La opacificación no intencional del Wirsung se presentó en el 32% de los pacientes, de ellos, 36 39,6% estaban en el grupo de hiperamilasemia, 6 66,7% en el grupo de 9 que presentaron pancreatitis y 7 13,5% en el grupo normal, observándose en mayor medida en el grupo de pacientes que presentaron pancreatitis post-CPRE con una relación estadísticamente significativa p = 0,000, al realizar la estimación del riesgo se encontró que este es 4,65 veces para desarrollar pancreatitis post-CPRE OR 4,65; IC 95% 1,11-19,46.